AU2002323286A1 - Human toxicologically relevant genes and arrays - Google Patents

Human toxicologically relevant genes and arrays

Info

Publication number
AU2002323286A1
AU2002323286A1 AU2002323286A AU2002323286A AU2002323286A1 AU 2002323286 A1 AU2002323286 A1 AU 2002323286A1 AU 2002323286 A AU2002323286 A AU 2002323286A AU 2002323286 A AU2002323286 A AU 2002323286A AU 2002323286 A1 AU2002323286 A1 AU 2002323286A1
Authority
AU
Australia
Prior art keywords
arrays
human
relevant genes
toxicologically relevant
toxicologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002323286A
Inventor
Karissa Adkins
Phillippe Alen
Robert T. Ii Dunn
Larry D. Kier
Robin E. Neft
Gavin G. Pickett
Katja Schmeiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phase-1 Molecular Toxicology Inc
Original Assignee
Phase-1 Molecular Toxicology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phase-1 Molecular Toxicology Inc filed Critical Phase-1 Molecular Toxicology Inc
Publication of AU2002323286A1 publication Critical patent/AU2002323286A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002323286A 2001-08-16 2002-08-16 Human toxicologically relevant genes and arrays Abandoned AU2002323286A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31308001P 2001-08-16 2001-08-16
US60/313,080 2001-08-16
PCT/US2002/026514 WO2003016500A2 (en) 2001-08-16 2002-08-16 Human toxicologically relevant genes and arrays

Publications (1)

Publication Number Publication Date
AU2002323286A1 true AU2002323286A1 (en) 2003-03-03

Family

ID=23214292

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002323286A Abandoned AU2002323286A1 (en) 2001-08-16 2002-08-16 Human toxicologically relevant genes and arrays

Country Status (3)

Country Link
EP (1) EP1427850A4 (en)
AU (1) AU2002323286A1 (en)
WO (1) WO2003016500A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050283854A1 (en) 2003-05-23 2005-12-22 Anton Krumm Recombinant vectors for use in position-independent transgene expression within chromatin
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2006060393A2 (en) * 2004-11-30 2006-06-08 Bg Medicine, Inc. Biological systems analysis
FR2890080B1 (en) * 2005-08-30 2012-12-14 Vigilent Technologies IN VITRO METHOD FOR TESTING THE TOXICITY OF A COMPOUND AND DEVICE FOR IMPLEMENTING SAID METHOD
WO2008023671A1 (en) * 2006-08-24 2008-02-28 Hiroshima University Method for highly amplifying target gene in mammalian cell and vector therefor
RU2693462C2 (en) 2010-05-03 2019-07-03 Курна, Инк. Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to sirtuin (sirt)
KR102165245B1 (en) * 2013-05-21 2020-10-13 한양대학교 에리카산학협력단 Method for determining probability of exposure to toxic chemicals
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
WO2021242819A1 (en) * 2020-05-29 2021-12-02 The Trustees Of The University Of Pennsylvania Compositions and methods of detecting respiratory viruses including coronaviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811231A (en) * 1993-01-21 1998-09-22 Pres. And Fellows Of Harvard College Methods and kits for eukaryotic gene profiling
US6160105A (en) * 1998-10-13 2000-12-12 Incyte Pharmaceuticals, Inc. Monitoring toxicological responses
WO2001011030A2 (en) * 1999-08-10 2001-02-15 Develogen Ag Für Entwicklungsbiologische Forschung Method and means for inducing cell-multiplication of non-active cells
AU1466001A (en) * 1999-11-05 2001-05-14 Phase-1 Molecular Toxicology Methods of determining individual hypersensitivity to an agent
US20020192671A1 (en) * 2001-01-23 2002-12-19 Castle Arthur L. Method and system for predicting the biological activity, including toxicology and toxicity, of substances
EP1534739A4 (en) * 2002-01-18 2006-05-31 Bristol Myers Squibb Co Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways

Also Published As

Publication number Publication date
WO2003016500A2 (en) 2003-02-27
WO2003016500A3 (en) 2003-06-19
EP1427850A2 (en) 2004-06-16
EP1427850A4 (en) 2006-02-08

Similar Documents

Publication Publication Date Title
AU2002348226A1 (en) Invasive therapeutic probe
WO2003018621A8 (en) Genes
EP1247815A3 (en) Modified oligonucleotides and uses thereof
AU2002356664A1 (en) Beta-amino-alpha-cyanoacrylates and their use as herbicides
AU2002336288A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
AU2002252976A1 (en) Hydrazones and their therapeutic use
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002323286A1 (en) Human toxicologically relevant genes and arrays
AU2002258387A1 (en) Rat toxicologically relevant genes and uses thereof
AU2003223878A1 (en) Heating conductor and use thereof
GB0127657D0 (en) Virulence genes and proteins and their use
AU2001268053A1 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
AU2001287269A1 (en) Human genes and expression products
AU2002240921A1 (en) Medane genes and proteins
AU2002322224A1 (en) Isp-1 and ctb-1 genes and uses thereof
AU2002303262A1 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof
EP1426443A4 (en) Novel human bmcc1 gene
AU2002953516A0 (en) Genetic therapy and genetic modification
GB0105922D0 (en) Genes and proteins, and their use
AU2002322013A1 (en) Therapeutic dna vaccination
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use
AU2002240094A1 (en) Anti-apoptopic gene scc-s2 and diagnostic and therapeutic uses thereof
AU2002226691A1 (en) Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase